BIO-Europe Spring 2019: Newcomer Tubulis Tackles ADC Technology Shortcomings

23 May 2019

• By Mike Ward

Newly established Tubulis has been set up to generate protein-drug conjugates using a novel platform approach deriving from two German academic institutes. CEO Dominik Schumacher spoke to Mike Ward at BIO-Europe Spring 2019.

BIO-Europe Spring 2019: Newcomer Tubulis Tackles ADC Technology Shortcomings

More from R&D

More from Scrip